We've found
184,457
clinical trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Newly Diagnosed Ewing Sarcoma Clinical Trial
Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Status: Enrolling
Updated: 4/17/2014
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Status: Enrolling
Updated: 4/17/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome Clinical Trial
Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Tumors Metastatic to Brain Clinical Trial
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Renal Failure (CKD 5) and Peritoneal Dialysis Clinical Trial
International Pediatric Peritoneal Biopsy Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Rheumatology, Orthopedics / Podiatry Clinical Trial
28mm Ceramic-on-Ceramic Total Hip Replacement Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Rheumatology, Orthopedics / Podiatry Clinical Trial
28mm Ceramic-on-Ceramic Total Hip Replacement Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Retroperitoneal Sarcoma Clinical Trial
Proton or Photon RT for Retroperitoneal Sarcomas
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 5/4/2016
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 3/30/2018
Click here to add this to my saved trials
Cancer, Solid Tumor Clinical Trial
Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)
Status: Enrolling,
Phase
I
Updated: 4/30/2014
Click here to add this to my saved trials
Cancer, Solid Tumor Clinical Trial
Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)
Status: Enrolling,
Phase
I
Updated: 4/30/2014
Click here to add this to my saved trials
Endocrinology Clinical Trial
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)
Status: Enrolling,
Phase
II
Updated: 4/24/2014
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Thrombosis Clinical Trial
Oral Rivaroxaban in Children With Venous Thrombosis
Status: Enrolling,
Phase
II
Updated: 7/19/2016
Click here to add this to my saved trials
We've found
184,457
clinical trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Plasma Cell Myeloma Clinical Trial
Updated: 12/31/1969
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Newly Diagnosed Ewing Sarcoma Clinical Trial
Updated: 12/31/1969
Irinotecan and Temozolomide in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Patients With Newly Diagnosed Ewing Sarcoma
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Updated: 12/31/1969
Shorter Duration Radiotherapy to Treat Prostate Cancer After Removal of the Prostate
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Hodgkin Lymphoma Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Updated: 4/17/2014
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Status: Enrolling
Updated: 4/17/2014
Click here to add this to my saved trials
Acute Kidney Injury Clinical Trial
Updated: 4/17/2014
Identification and Validation of Biomarkers of Acute Kidney Injury Recovery
Status: Enrolling
Updated: 4/17/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 5/4/2017
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery
Status: Enrolling,
Phase
III
Updated: 5/4/2017
Click here to add this to my saved trials
Hypoplastic Left Heart Syndrome Clinical Trial
Updated: 12/31/1969
Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Tumors Metastatic to Brain Clinical Trial
Updated: 12/31/1969
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Renal Failure (CKD 5) and Peritoneal Dialysis Clinical Trial
Updated: 12/31/1969
International Pediatric Peritoneal Biopsy Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Updated: 2/28/2014
A Study to Evaluate the Safety and Efficacy of MK-3102 Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027)
Status: Enrolling,
Phase
III
Updated: 2/28/2014
Click here to add this to my saved trials
Rheumatology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
28mm Ceramic-on-Ceramic Total Hip Replacement Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Rheumatology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
28mm Ceramic-on-Ceramic Total Hip Replacement Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Retroperitoneal Sarcoma Clinical Trial
Updated: 12/31/1969
Proton or Photon RT for Retroperitoneal Sarcomas
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Heart Failure Clinical Trial
Updated: 12/31/1969
The Product Surveillance Registry REVERSE Post Approval Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Migraine Disorders Clinical Trial
Updated: 5/4/2016
A Study Using Botulinum Toxin Type A as Headache Prophylaxis in Adolescents With Chronic Migraine
Status: Enrolling,
Phase
III
Updated: 5/4/2016
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 3/30/2018
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 3/30/2018
Click here to add this to my saved trials
Cancer, Solid Tumor Clinical Trial
Updated: 4/30/2014
Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)
Status: Enrolling,
Phase
I
Updated: 4/30/2014
Click here to add this to my saved trials
Cancer, Solid Tumor Clinical Trial
Updated: 4/30/2014
Study of MK-3475 in Participants With Progressive Locally Advanced or Metastatic Carcinoma, Melanoma, or Non-small Cell Lung Carcinoma (P07990/MK-3475-001/KEYNOTE-001)
Status: Enrolling,
Phase
I
Updated: 4/30/2014
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology Clinical Trial
Updated: 12/31/1969
Study to Assess Safety & Efficacy of Sitagliptin as Initial Oral Therapy for Treatment of Type 2 Diabetes Mellitus in Pediatric Participants. (MK-0431-083)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 4/24/2017
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Updated: 12/31/1969
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Updated: 12/31/1969
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Updated: 12/31/1969
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Updated: 12/31/1969
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Updated: 12/31/1969
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Updated: 12/31/1969
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Updated: 12/31/1969
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Updated: 12/31/1969
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Updated: 12/31/1969
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Fibrosing Colonopathy Clinical Trial
Updated: 12/31/1969
Long-term Study in US Cystic Fibrosis Patients Receiving Digestive Enzyme Supplements to Assess Narrowing of the Large Intestine Causing Adverse Intestinal Symptoms (Fibrosing Colonopathy)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Asthma Clinical Trial
Updated: 4/24/2014
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)
Status: Enrolling,
Phase
II
Updated: 4/24/2014
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Updated: 8/16/2012
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Venous Thrombosis Clinical Trial
Updated: 7/19/2016
Oral Rivaroxaban in Children With Venous Thrombosis
Status: Enrolling,
Phase
II
Updated: 7/19/2016
Click here to add this to my saved trials